Overview Fundamentals API Earnings EOD API Sample Code Pricing

Marinus Pharmaceuticals Inc (MRNS NASDAQ) stock market data APIs

$1.43 -0.07(-4.7%) as of July 22, 2024
Price chart is built with Anychart

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY (ganaxolone), an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, and tuberous sclerosis complex. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation and Tenacia Biotechnology (Shanghai) Co., Ltd. Marinus Pharmaceuticals, Inc. was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

Marinus Pharmaceuticals Inc Financial Data Overview

78 555 K
54 934 K
28 288 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MRNS',
Type: 'Common Stock',
Name: 'Marinus Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00253KMF6',
CIK: '1267813',
EmployerIdNumber: '20-0198082',
FiscalYearEnd: 'December',
IPODate: '2014-07-31',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Marinus Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 28 288 K
  • EBITDA -129 387 000
  • Earnings Per Share -2.64
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Marinus Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -0.66

Get Marinus Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?